×
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
NASDAQ:NSTG

NanoString Technologies Stock Forecast, Price & News

$14.57
+0.20 (+1.39%)
(As of 07/7/2022 09:52 AM ET)
Add
Compare
Today's Range
$14.02
$14.66
50-Day Range
$12.29
$19.86
52-Week Range
$11.81
$63.91
Volume
804 shs
Average Volume
712,707 shs
Market Capitalization
$676.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.67

NanoString Technologies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
217.8% Upside
$45.67 Price Target
Short Interest
Healthy
7.44% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.07
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$24,137 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.64) to ($2.07) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.14 out of 5 stars

Medical Sector

322nd out of 1,433 stocks

Biological Products, Except Diagnostic Industry

46th out of 220 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive NSTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter.

NanoString Technologies logo

About NanoString Technologies (NASDAQ:NSTG) Stock

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

NSTG Stock News Headlines

What 4 Analyst Ratings Have To Say About NanoString Technologies
NanoString Technologies Misses Q1 EPS by 30c
See More Headlines

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NSTG
Employees
766
Year Founded
N/A

Company Calendar

Last Earnings
5/10/2022
Today
7/07/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$45.67
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+213.4%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
4 Analysts

Profitability

Net Income
$-115,250,000.00
Pretax Margin
-87.76%

Debt

Sales & Book Value

Annual Sales
$145.09 million
Book Value
$3.88 per share

Miscellaneous

Free Float
45,116,000
Market Cap
$676.34 million
Optionable
Optionable
Beta
2.00














NanoString Technologies Frequently Asked Questions

Should I buy or sell NanoString Technologies stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NanoString Technologies stock.
View analyst ratings for NanoString Technologies
or view top-rated stocks.

What is NanoString Technologies' stock price forecast for 2022?

4 analysts have issued twelve-month price objectives for NanoString Technologies' stock. Their NSTG stock forecasts range from $30.00 to $70.00. On average, they predict NanoString Technologies' stock price to reach $45.67 in the next year. This suggests a possible upside of 213.4% from the stock's current price.
View analysts' price targets for NanoString Technologies
or view top-rated stocks among Wall Street analysts.

How has NanoString Technologies' stock performed in 2022?

NanoString Technologies' stock was trading at $42.23 at the beginning of 2022. Since then, NSTG stock has decreased by 65.5% and is now trading at $14.57.
View the best growth stocks for 2022 here
.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for NanoString Technologies
.

How were NanoString Technologies' earnings last quarter?

NanoString Technologies, Inc. (NASDAQ:NSTG) released its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported ($0.86) EPS for the quarter, missing analysts' consensus estimates of ($0.54) by $0.32. The biotechnology company had revenue of $31.08 million for the quarter, compared to analyst estimates of $30.95 million. NanoString Technologies had a negative trailing twelve-month return on equity of 68.57% and a negative net margin of 87.89%. The firm's revenue was down 1.7% on a year-over-year basis. During the same period last year, the business posted ($0.62) earnings per share.
View NanoString Technologies' earnings history
.

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 45, Pay $1.12M) (LinkedIn Profile)
  • Mr. K. Thomas Bailey M.B.A., Chief Financial Officer (Age 53, Pay $629.08k) (LinkedIn Profile)
  • Dr. Joseph M. Beechem, Chief Scientific Officer and Sr. VP of R&D (Age 64, Pay $630.82k) (LinkedIn Profile)
  • Mr. J. Chad Brown, Sr. Advisor (Age 64, Pay $599.59k)
  • Mr. Mark A. Winham, Sr. VP of Operations
  • Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
  • Ms. Kathryn Surace-Smith, Sr. VP of HR & Legal Affairs and Corp. Sec. (Age 63)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 55)
  • Elizabeth Schneider Ph.D., Sr. Global Marketing Mang.
  • Dr. Mary Tedd Allen, Sr. VP of Strategic Initiatives (Age 59)

What is Brad Gray's approval rating as NanoString Technologies' CEO?

36 employees have rated NanoString Technologies CEO Brad Gray on Glassdoor.com. Brad Gray has an approval rating of 65% among NanoString Technologies' employees.

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO).

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $14.57.

How much money does NanoString Technologies make?

NanoString Technologies (NASDAQ:NSTG) has a market capitalization of $676.34 million and generates $145.09 million in revenue each year. The biotechnology company earns $-115,250,000.00 in net income (profit) each year or ($2.79) on an earnings per share basis.

How many employees does NanoString Technologies have?

NanoString Technologies employs 766 workers across the globe.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The official website for NanoString Technologies is www.nanostring.com. The biotechnology company can be reached via phone at (888) 358-6266, via email at dfarrell@nanostring.com, or via fax at 206-378-6288.

This page (NASDAQ:NSTG) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.